Physisorption of Affinity Ligands Facilitates Extracellular Vesicle Detection with Low Non-Specific Binding to Plasmonic Gold Substrates.

antibody immobilization extracellular vesicles physisorption plasmonic sensing surface chemistry

Journal

ACS applied materials & interfaces
ISSN: 1944-8252
Titre abrégé: ACS Appl Mater Interfaces
Pays: United States
ID NLM: 101504991

Informations de publication

Date de publication:
02 Jun 2022
Historique:
entrez: 2 6 2022
pubmed: 3 6 2022
medline: 3 6 2022
Statut: aheadofprint

Résumé

Plasmonic biosensors are increasingly being used for the analysis of extracellular vesicles (EVs) originating from disease areas. However, the high non-specific binding of EVs to a gold-sensing surface has been a critical problem and hindered the true translational potential. Here, we report that direct antibody immobilization on the plasmonic gold surface via physisorption shows excellent capture of cancer-derived EVs with ultralow non-specific binding even at very high concentrations. Contrary to commonly used methods that involve thiol-based linker attachment and an EDC/sulfo-NHS reaction, we show a higher specific capture rate and >50-fold lower non-specific on citrate-capped plain and nanopatterned gold surfaces. The method provides a simple, fast, and reproducible means to functionalize plasmonic gold surfaces with antibodies for robust EV biosensing.

Identifiants

pubmed: 35653580
doi: 10.1021/acsami.2c07317
pmc: PMC9715849
mid: NIHMS1821342
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIGMS NIH HHS
ID : R01 GM138778
Pays : United States
Organisme : NCI NIH HHS
ID : R21 CA217662
Pays : United States

Références

Chem Rev. 2021 Jul 14;121(13):8095-8160
pubmed: 34105942
ACS Nano. 2017 Nov 28;11(11):11182-11193
pubmed: 29019651
Science. 2020 Feb 7;367(6478):
pubmed: 32029601
Anal Chem. 2008 Oct 15;80(20):7670-7
pubmed: 18811215
J Biol Eng. 2019 Jul 10;13:63
pubmed: 31333759
Nat Rev Cardiol. 2017 May;14(5):259-272
pubmed: 28150804
Anal Chim Acta. 2012 Jan 27;712:138-44
pubmed: 22177077
Chem Rev. 2005 Apr;105(4):1103-69
pubmed: 15826011
Langmuir. 2019 Aug 13;35(32):10601-10609
pubmed: 31335148
N Engl J Med. 2018 Sep 06;379(10):958-966
pubmed: 30184457
Nat Rev Drug Discov. 2013 May;12(5):347-57
pubmed: 23584393
Anal Chem. 2010 Aug 1;82(15):6401-8
pubmed: 20669994
Nat Biomed Eng. 2021 Jul;5(7):678-689
pubmed: 34183802
Langmuir. 2010 Jan 19;26(2):809-14
pubmed: 19725548
Eur J Pharm Biopharm. 2017 Sep;118:56-61
pubmed: 28396279
Nat Rev Cancer. 2020 Dec;20(12):697-709
pubmed: 32958932
Brain. 2021 Feb 12;144(1):288-309
pubmed: 33246331
Sci Rep. 2021 Nov 19;11(1):22580
pubmed: 34799635
Adv Biosyst. 2020 Dec;4(12):e2000003
pubmed: 32815321
Anal Chem. 2019 Aug 6;91(15):10001-10007
pubmed: 31269392
ACS Nano. 2016 Feb 23;10(2):1802-9
pubmed: 26808216
Angew Chem Int Ed Engl. 2008;47(50):9618-47
pubmed: 19025742
Theranostics. 2018 Apr 9;8(10):2709-2721
pubmed: 29774070
Front Immunol. 2018 Dec 13;9:2723
pubmed: 30619239
Anal Chem. 2009 Aug 1;81(15):6449-57
pubmed: 19572546
Nat Rev Clin Oncol. 2018 Oct;15(10):617-638
pubmed: 29795272
MAbs. 2019 May/Jun;11(4):757-766
pubmed: 30894096
ACS Nano. 2020 Nov 24;14(11):14528-14548
pubmed: 33119256
Adv Biosyst. 2020 Dec;4(12):e1900310
pubmed: 32351054
Front Chem. 2014 Jul 15;2:48
pubmed: 25077142
Langmuir. 2014 Apr 29;30(16):4545-50
pubmed: 24720739
Nat Biotechnol. 2014 May;32(5):490-5
pubmed: 24752081
ACS Appl Mater Interfaces. 2014 Dec 10;6(23):21184-92
pubmed: 25347206
Nat Rev Rheumatol. 2014 Jun;10(6):356-64
pubmed: 24535546
Bioconjug Chem. 2017 Nov 15;28(11):2737-2746
pubmed: 28984436
Sci Transl Med. 2020 Jun 10;12(547):
pubmed: 32522804
Nat Commun. 2019 Aug 26;10(1):3854
pubmed: 31451692
Langmuir. 2020 Aug 11;36(31):9241-9249
pubmed: 32686419
ACS Appl Mater Interfaces. 2019 Sep 11;11(36):32758-32768
pubmed: 31381297
Biomacromolecules. 2007 Jun;8(6):1775-89
pubmed: 17444679
Biotechnol Prog. 2002 May-Jun;18(3):509-13
pubmed: 12052067
J Extracell Vesicles. 2019 Jun 19;8(1):1597603
pubmed: 31258878
Clin Cancer Res. 2015 Nov 1;21(21):4811-8
pubmed: 26169969
Sci Adv. 2022 Apr 22;8(16):eabm3453
pubmed: 35452280
Anal Chem. 2014 Sep 2;86(17):8857-64
pubmed: 25090139
Cell. 2020 Aug 20;182(4):1044-1061.e18
pubmed: 32795414
Sci Transl Med. 2017 May 24;9(391):
pubmed: 28539469
Chem Rev. 2018 Feb 28;118(4):1917-1950
pubmed: 29384376
Circ Res. 2017 May 12;120(10):1649-1657
pubmed: 28495995
JAMA Neurol. 2019 Apr 1;76(4):402-404
pubmed: 30640380

Auteurs

Kihyeun Kim (K)

Center for Systems Biology, Massachusetts General Hospital, Boston, Massachusetts 02114, United States.

Taehwang Son (T)

Center for Systems Biology, Massachusetts General Hospital, Boston, Massachusetts 02114, United States.

Jae-Sang Hong (JS)

Center for Systems Biology, Massachusetts General Hospital, Boston, Massachusetts 02114, United States.

Tae Joon Kwak (TJ)

Center for Systems Biology, Massachusetts General Hospital, Boston, Massachusetts 02114, United States.

Mi Ho Jeong (MH)

Center for Systems Biology, Massachusetts General Hospital, Boston, Massachusetts 02114, United States.

Ralph Weissleder (R)

Center for Systems Biology, Massachusetts General Hospital, Boston, Massachusetts 02114, United States.
Department of Radiology, Massachusetts General Hospital, Boston, Massachusetts 02114, United States.
Cancer Center, Massachusetts General Hospital, Boston, Massachusetts 02114, United States.
Department of Systems Biology, Harvard Medical School, Boston, Massachusetts 02115, United States.

Hyungsoon Im (H)

Center for Systems Biology, Massachusetts General Hospital, Boston, Massachusetts 02114, United States.
Department of Radiology, Massachusetts General Hospital, Boston, Massachusetts 02114, United States.

Classifications MeSH